Name | [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate |
Description | [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate ([D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate (96736-12-8 free base)) is a broad spectrum neuropeptide inverse agonist and antagonist. Potent full inverse agonist for the ghrelin receptor (EC50 = 5.2 nM); diminishes constitutive ghrelin receptor signaling. Also antagonist at tachykinin, bradykinin, CCK and bombesin receptors. Induces apoptosis and inhibits cancer cell growth in vitro. |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 2.5 mM, Sonication is recommended.
|
Keywords | CCK | [D-Arg-1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate | [DArg1,DPhe5,DTrp7,9,Leu11]Substance P acetate | [D Arg1,D Phe5,D Trp7,9,Leu11] Substance P acetate |
Inhibitors Related | PHA-767491 | GV-150013X | (Iso)-FK-480 | Itriglumide | GV150013 | XL413 hydrochloride | Proglumide | Lintitript | N-Cbz-DL-tryptophan | A-65186 | Pranazepide | Spiroglumide |
Related Compound Libraries | Bioactive Compound Library | Peptide Compound Library | Inhibitor Library | NO PAINS Compound Library | Bioactive Compounds Library Max | GPCR Compound Library | Anti-Cancer Compound Library |